image
Ultragenyx Pharmaceutical Inc. RARE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 44.75
-6.07 %
$ 4.13 B
Market Cap
-7.05
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 19.52% 14.25% 12.28%
Annual Report FY 10-K 2022-12-31 3.39% -55.81% -69.99%
Annual Report FY 10-K 2021-12-31 29.66% -143.36% -15.64%
Annual Report FY 10-K 2020-12-31 161.32% 53.67% 22.17%
Annual Report FY 10-K 2019-12-31 101.41% -103.80% -14.22%
Annual Report FY 10-K 2018-12-31 1871.48% 34.60% -12.90%
Annual Report FY 10-K 2017-12-31 1863.91% -22.88% -32.63%
Annual Report FY 10-K 2016-12-31 0.00% -68.85% -67.87%
Annual Report FY 10-K 2015-12-31 0.00% -143.50% -160.20%
Annual Report FY 10-K 2014-12-31 0.00% -70.52% -75.89%
Annual Report FY 10-K 2013-12-31 0.00% -114.71% -101.94%
Annual Report FY 10-K 2012-12-31 0.00% -138.49% -143.64%
Annual Report FY 10-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 42.27% 16.37% 9.04%
Quarterly Report Q2 8-K 2024-06-30 35.75% 17.66% 21.35%
Quarterly Report Q1 8-K 2024-03-31 8.30% -4.09% -7.30%
Quarterly Report Q4 8-K 2023-12-31 23.27% 18.86% 16.19%
Quarterly Report Q3 8-K 2023-09-30 8.10% 34.87% 35.53%
Quarterly Report Q2 8-K 2023-06-30 21.23% -1.05% -4.49%
Quarterly Report Q1 8-K 2023-03-31 25.72% -7.65% -12.79%
Quarterly Report Q4 8-K 2022-12-31 23.93% -23.99% -41.99%
Quarterly Report Q3 8-K 2022-09-30 11.09% -235.77% -150.55%
Quarterly Report Q2 8-K 2022-06-30 2.72% -29.19% -71.06%
Quarterly Report Q1 8-K 2022-03-31 -19.58% -11.88% -28.21%
Quarterly Report Q4 8-K 2021-12-31 -8.91% -410.01% -6.75%
Quarterly Report Q3 8-K 2021-09-30 0.22% -6.03% -78.53%
Quarterly Report Q2 8-K 2021-06-30 40.94% -483.62% -31.28%
Quarterly Report Q1 8-K 2021-03-31 173.75% -14.38% 11.68%
Quarterly Report Q4 8-K 2020-12-31 157.19% 74.40% -1.72%
Quarterly Report Q3 8-K 2020-09-30 215.78% 39.07% 57.37%
Quarterly Report Q2 8-K 2020-06-30 155.53% 125.53% 43.94%
Quarterly Report Q1 8-K 2020-03-31 99.81% -23.02% -21.62%
Quarterly Report Q4 8-K 2019-12-31 118.89% -6.81% -4.55%
Quarterly Report Q3 8-K 2019-09-30 119.33% -29.42% -31.67%
Quarterly Report Q2 8-K 2019-06-30 88.75% -88.08% -18.52%
Quarterly Report Q1 8-K 2019-03-31 70.20% -319.82% -2.83%
Quarterly Report Q4 8-K 2018-12-31 573.61% -7.46% 6.71%
Quarterly Report Q3 8-K 2018-09-30 5840.91% -10.20% -7.09%
Quarterly Report Q2 8-K 2018-06-30 0.00% 27.66% -20.98%
Quarterly Report Q1 8-K 2018-03-31 0.00% 144.30% -37.93%
Quarterly Report Q4 8-K 2017-12-31 48180.00% -14.65% -37.26%
Quarterly Report Q3 8-K 2017-09-30 78.38% -22.06% -27.26%
Quarterly Report Q2 8-K 2017-06-30 0.00% -28.05% -35.12%
Quarterly Report Q1 8-K 2017-03-31 0.00% -29.44% -30.46%
Quarterly Report Q4 8-K 2016-12-31 0.00% -29.10% -25.63%
Quarterly Report Q3 8-K 2016-09-30 0.00% -65.44% -64.72%
Quarterly Report Q2 8-K 2016-06-30 0.00% -91.10% -92.60%
Quarterly Report Q1 8-K 2016-03-31 0.00% -146.77% -149.38%
Quarterly Report Q4 8-K 2015-12-31 0.00% -229.91% -231.45%
Quarterly Report Q3 8-K 2015-09-30 0.00% -147.54% -152.20%
Quarterly Report Q2 8-K 2015-06-30 0.00% -119.26% -120.64%
Quarterly Report Q1 8-K 2015-03-31 0.00% -56.85% -107.97%
Quarterly Report Q4 8-K 2014-12-31 0.00% -47.90% -77.88%
Quarterly Report Q3 8-K 2014-09-30 0.00% -88.05% -104.03%
Quarterly Report Q2 8-K 2014-06-30 0.00% -58.15% -65.65%
Quarterly Report Q1 8-K 2014-03-31 0.00% -102.38% -53.24%
Quarterly Report Q4 8-K 2013-12-31 0.00% -129.55% -103.61%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%